Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial.
Journal: Lancet (London, England)
Published: March 21, 2025
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial.
Journal: Lancet (London, England)
Published: August 08, 2024
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 17, 2023
Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
Journal: Journal of diabetes and its complications
Published: June 22, 2023
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 09, 2023
Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 26, 2022
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D.
Journal: Diabetes care
Published: December 19, 2019
Time-Averaged Self-Monitored Blood Glucose Values Estimate Hemoglobin A1c Outcomes in Patients With Type 1 Diabetes.
Journal: Journal of diabetes science and technology
Published: March 09, 2018
Effects of hepato-preferential basal insulin peglispro on nuclear magnetic resonance biomarkers lipoprotein insulin resistance index and GlycA in patients with diabetes.
Journal: Biomarkers in medicine
Published: November 22, 2017
Relationship of Glucose Variability With Glycated Hemoglobin and Daily Mean Glucose: A Post Hoc Analysis of Data From 5 Phase 3 Studies.
Journal: Journal of diabetes science and technology
Published: October 24, 2017
Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: October 23, 2017
Dose Unit Establishment for a New Basal Insulin Using Joint Modeling of Insulin Dose and Glycemic Response.
Journal: Journal of diabetes science and technology
Published: May 04, 2017
Last Updated: 09/26/2026